We are live on
!
Find out more
CCG
Chatham Capital Group Portfolio holdings
AUM
$783M
1-Year Est. Return
31.99%
This Fund
S&P 500
This Quarter
Est. Return
+2.23%
1 Year Est. Return
+31.99%
3 Year Est. Return
+89.87%
5 Year Est. Return
+115.31%
10 Year Est. Return
+283.24%
AUM
$361M
AUM Growth
+$3.39M
(+0.95%)
Cap. Flow
-$3.16M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
36.52%
Holding
162
New
10
Increased
58
Reduced
55
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$879K |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$877K |
| 3 |
Southside Bancshares
SBSI
|
+$835K |
| 4 |
Emergent Biosolutions
EBS
|
+$583K |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$512K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLFS
POWERSHARES S&P SMALLCAP FINANCIALS PORTFOLIO
XLFS
|
+$2.06M |
| 2 |
ProShares UltraShort S&P500
SDS
|
+$1.75M |
| 3 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$1.61M |
| 4 |
ResMed
RMD
|
+$1.54M |
| 5 |
SNCR
Synchronoss Technologies
SNCR
|
+$820K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.99% |
| 2 | Healthcare | 7.27% |
| 3 | Industrials | 7.25% |
| 4 | Technology | 7.04% |
| 5 | Consumer Staples | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Genworth Financial
GNW
$3.86B
| – | – |
-14,000
| Closed | -$58K |
|
152
GSK
GSK
$104B
| – | – |
-5,080
| Closed | -$268K |
|
153
Lowe's Companies
LOW
$117B
| – | – |
-2,469
| Closed | -$203K |
|
154
Prospect Capital
PSEC
$1.13B
| – | – |
-10,000
| Closed | -$90K |
|
|
155
ResMed
RMD
$28.9B
| – | – |
-21,405
| Closed | -$1.54M |
|
|
156
ProShares UltraShort S&P500
SDS
$390M
| – | – |
-1,300
| Closed | -$1.75M |
|
|
SNCR
157
DELISTED
Synchronoss Technologies
SNCR
| – | – |
-3,733
| Closed | -$820K |
|
158
Scorpio Tankers
STNG
$3.81B
| – | – |
-1,000
| Closed | -$44K |
|
|
PWE
159
DELISTED
Penn West Energy Petroleum Ltd
PWE
| – | – |
-17,500
| Closed | -$30K |
|
|
UN
160
DELISTED
Unilever NV New York Registry Shares
UN
| – | – |
-5,000
| Closed | -$248K |
|
|
ETP
161
DELISTED
Energy Transfer Partners L.p.
ETP
| – | – |
-6,340
| Closed | -$232K |
|
|
XLFS
162
DELISTED
POWERSHARES S&P SMALLCAP FINANCIALS PORTFOLIO
XLFS
| – | – |
-40,169
| Closed | -$2.06M |
|
Similar funds
NCM
MO
TIS
QCMNJ
GA
TCMX
RTM
SG
Chatham Capital Group's Q2 2017 Portfolio in Review
As of Q2 2017, Chatham Capital Group held 162 positions worth $361M, up 0.95% from $358M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Chatham Capital Group's Q2 2017 filing shows 10 new, 58 increased, 55 reduced and 12 closed positions. Its largest new stake was BioTelemetry, Inc.: 29,450 shares worth $985K. The largest sale was POWERSHARES S&P SMALLCAP FINANCIALS PORTFOLIO, an estimated $2.06M.
By sector, the portfolio is most concentrated in Financials at 9% of assets, up from 8.3% a quarter earlier, followed by Healthcare and Industrials.
- Chatham Capital Group's largest Q2 2017 buy was BioTelemetry, Inc.: 29,450 shares worth $985K.
- Chatham Capital Group added most to Vanguard FTSE Europe ETF in Q2 2017, an estimated $512K increase.
- Chatham Capital Group's biggest Q2 2017 reduction was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF, cutting an estimated $1.61M.
- Chatham Capital Group fully exited POWERSHARES S&P SMALLCAP FINANCIALS PORTFOLIO in Q2 2017, selling an estimated $2.06M.
- Chatham Capital Group's ten largest holdings make up 37% of its $361M portfolio in Q2 2017.
- Chatham Capital Group opened 10 new positions and closed 12 in Q2 2017.
- Chatham Capital Group's portfolio value rose 0.95% quarter-over-quarter to $361M.
Based on Chatham Capital Group's 13F filing for Q2 2017, filed 9 Aug 2017.